Group 1 - Health元's stock price increased by 0.99% to 12.21 yuan per share, with a total market capitalization of 22.338 billion yuan and a trading volume of 3.79 billion yuan, marking a cumulative increase of 5.71% over the past seven days [1] - The company, founded on December 18, 1992, and listed on June 8, 2001, operates as a comprehensive pharmaceutical enterprise engaged in the research, development, and production of traditional Chinese medicine, health products, and Western medicine [1] - The main business revenue composition includes: chemical preparations 47.71%, chemical raw materials and intermediates 31.97%, traditional Chinese medicine preparations 10.28%, diagnostic reagents and equipment 4.74%, health food 3.08%, biological products 1.20%, and others 0.86% [1] Group 2 - Longxin Fund has one fund heavily invested in Health元, with Longxin Medical Health Mixed (LOF) A (163001) reducing its holdings by 57,600 shares in the third quarter, now holding 236,000 shares, representing 2.18% of the fund's net value [2] - The fund has generated a floating profit of approximately 28,300 yuan today and a total of 155,800 yuan during the seven-day increase [2] - Longxin Medical Health Mixed (LOF) A (163001) was established on March 26, 2010, with a current scale of 128 million yuan, yielding 8.03% this year and 33.13% over the past year [2]
健康元股价连续7天上涨累计涨幅5.71%,长信基金旗下1只基金持23.6万股,浮盈赚取15.58万元